Tech Company Financing Transactions
MacuSight Funding Round
MacuSight closed a $8 million funding round on 9/30/2006. Investors included Alloy Ventures and Frazier Healthcare Partners.
Transaction Overview
Company Name
Announced On
9/30/2006
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Undisclosed
Investors
Frazier Healthcare Partners (Nathan Every)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
32980 Alvarado-Niles Road 846
Union City, CA 94587
USA
Union City, CA 94587
USA
Phone
Website
Email Address
Overview
MacuSight is a privately-held pharmaceutical company focused on developing innovative therapeutics for the treatment of severe ocular diseases and conditions. The company is dedicated to preserving patients' vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Weber
Chief Medical Officer
Joel Naor
VP - General Counsel
Philip Reilly
VP - Operations
Gerald Wroblewski
VP - R & D
Thierry Nivaggioli
Browse more venture capital transactions:
Prev: 9/30/2006: Juniper Medical venture capital transaction
Next: 9/30/2006: Duck Creek Technologies venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on all VC transactions involving tech companies. All VC database entries on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs